公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2010 | Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma | Yeo W.; PEI-JER CHEN ; Furuse J.; Han K.-H.; CHIUN HSU ; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L. | BMC Cancer | 4 | 4 | |
2010 | Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion | PEI-JER CHEN ; Furuse J.; Han K.-H.; CHIUN HSU ; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W. | Liver International | 37 | 34 | |
2010 | Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib | Vogel C; Chan A; Gril B; Kim S.-B; Kurebayashi J; Liu L; YEN-SHEN LU ; Moon H. | Japanese Journal of Clinical Oncology | 21 | 19 | |
2010 | The prevalence and assessment of ErbB2-positive breast cancer in Asia: A literature survey | Tan Y.O; Han S; YEN-SHEN LU ; Yip C.-H; Sunpaweravong P; Jeong J; Caguioa P.B; Aggarwal S; Yeoh E.M; Moon H. | Cancer | 17 | 16 |